Antimicrobial resistance (AMR) was declared a top 10 global public health threat in 20191, however, recent reports reveal that actions and investments are still needed to prevent a potential AMR public health crisis. AMR occurs when bacteria, fungi, viruses, and parasites mutate naturally over time and no longer respond to modern medicines— a problem exacerbated by the misuse and overuse of antimicrobials.

bioMérieux provides the most complete solution to support antimicrobial stewardship (AMS) initiatives. We partner with healthcare systems and professionals like you, contributing expertise and diagnostic innovation that is adaptable and scalable to current and future AMS needs.

"We are losing kids not from their cancer, but from infections antibiotics cannot fight."

Menia Koukougianni was thrust into the conversation of AMR after her daughter's cancer treatment was interrupted by a new threat— a healthcare acquired bacterial infection. Here Menia expresses the need for better education and collaboration to ensure antibiotics are used wisely in patient therapy, thereby remaining lifesaving for future generations.

a woman wearing a labcoat and stethoscope sits at a conference table with a report in front of her; in the background a man in scrubs, standing, confers with a man in a labcoat sitting at the conference table and reviewing a laptop screen

Antimicrobial Stewardship Is The Best Solution To Combat Antimicrobial Resistance

AMS is defined as coordinated interventions which seek to limit patient exposure to antibiotics. The goal of AMS initiatives is to ensure that the right antibiotic is given to the right patient at the right time, with the right dose and via the right route— causing the least harm to the patient. In realistic terms, it is a multidisciplinary approach that aims to ensure that patients benefit from the most effective antibiotic treatments, while limiting the side effects and costs of unnecessary treatments.

You can do more with Stewardship

  • Detect, prevent, and control multi-drug resistant infections
  • Minimize the risk of healthcare-associated infections (HAI)
  • Optimize the use of antibiotics
  • Monitor and track resistance trends

Do More With What You Have

Get Started Today

Antimicrobial Stewardship Initiatives Have Proven Medical And Economic Benefits

Initiating a mixed-intervention plan that evolves over time will enable your health system to optimize antibiotic use, increase efficiencies, and help slow the spread of AMR.

Explore a Consolidated Review of AMS Scientific Evidence

Diagnostics Are At The Heart Of Antimicrobial Stewardship

Luke Moore, PhD, an infectious disease physician and clinical microbiologist in London, describes how optimized diagnostics and data-driven solutions can benefit AMS initiatives by:

  • Improving speed to diagnosis in a cost-effective manner
  • Informing infection prevention measures
  • Monitoring and analyzing resistance patterns throughout institutions
  • Supporting clinical decision-making at both the patient and population level

bioMérieux’s Diagnostic Solutions Advance Antimicrobial Stewardship

bioMérieux provides the most complete solution to support AMS initiatives with 80% of our product portfolio dedicated to the fight against AMR. We help healthcare systems maximize diagnostics and data to detect, target, and treat drug-resistant infections— with integrated solutions that support the right antibiotics for the right person and only when necessary. Discover more about our adaptable and scalable solutions that could help you more confidently deliver evidence-based clinical recommendations along the entire patient care pathway.


Explore bioMérieux's Complete Solution for AMS

Take Me There

a woman in protective glasses and a protective smock loads slides into bioMérieux's VITEK 2

bioMérieux's Complete Solution for Antimicrobial Stewardship Along the Patient Pathway:

Infographic breaking bioMérieux diagnostic products into categories based on what stage of the Antimicribial Stewardship pathway they address

Product availability varies by country. Consult your bioMérieux sales representative.

Ready to Unlock the Value of
Optimized Diagnostics for Optimized Therapy?

Register to receive actionable information about how to optimize the use of diagnostics and data to improve patient management and slow the spread of AMR.

1 WHO. Antimicrobial resistance. Published October 13, 2020.

bioMérieux's Diverse Resources Support Your Stewardship Initiatives

illustrated icon of computer screen with learning content

Free-access to medical education webinars, tutorials, and other resources.

illustrated icon of a compass

Explore on-demand information, timely thought leadership, and diagnostic solutions supporting the fight against AMR.

illustrated icon of a computer screen displaying an open book

Listen to clinical insights and interviews with microbiology experts about the value of diagnostics.

« Return to Top

Access Consolidated Review of the Benefits of AMS Practices

Access Andrea Prinzi's Editorial